Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

BDTX

Black Diamond Therapeutics Inc

Apr 26 • 04:00PM ET

5.89

Dollar change +0.78
Percentage change 15.26	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF IWC DFAT DFAU BMED DFUS DFAC DFSU

Index	-	P/E	-	EPS (ttm)	-1.92	Insider Own	26.27%	Shs Outstand	51.65M	Perf Week	11.98%
Market Cap	304.63M	Forward P/E	-	EPS next Y	-1.79	Insider Trans	0.00%	Shs Float	38.13M	Perf Month	20.20%
Income	-82.44M	PEG	-	EPS next Q	-0.43	Inst Own	68.17%	Short Float	4.62%	Perf Quarter	103.10%
Sales	0.00M	P/S	-	EPS this Y	8.95%	Inst Trans	0.10%	Short Ratio	2.73	Perf Half Y	208.38%
Book/sh	2.26	P/B	2.61	EPS next Y	-4.49%	ROA	-52.37%	Short Interest	1.76M	Perf Year	300.68%
Cash/sh	2.54	P/C	2.32	EPS next 5Y	-	ROE	-70.94%	52W Range	1.43 - 6.85	Perf YTD	109.61%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-49.79%	ROI	-59.34%	52W High	-14.01%	Beta	2.60
Dividend TTM	-	Quick Ratio	6.82	Sales past 5Y	0.00%	Gross Margin	-	52W Low	311.89%	ATR (14)	0.44
Dividend Ex-Date	-	Current Ratio	6.82	EPS Y/Y TTM	23.34%	Oper. Margin	0.00%	RSI (14)	62.60	Volatility	8.39% 8.18%
Employees	54	Debt/Eq	0.22	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	12.80
Option/Short	Yes / Yes	LT Debt/Eq	0.19	EPS Q/Q	35.12%	Payout	-	Rel Volume	0.88	Prev Close	5.11
Sales Surprise	-	EPS Surprise	27.04%	Sales Q/Q	-	Earnings	Mar 12 BMO	Avg Volume	644.93K	Price	5.89
SMA20	13.86%	SMA50	20.06%	SMA200	69.22%	Trades		Volume	566,432	Change	15.26%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-14-23	Initiated	Piper Sandler	Overweight
Jun-30-23	Upgrade	Stifel	Hold → Buy	$2 → $10
Jun-28-23	Upgrade	H.C. Wainwright	Neutral → Buy	$11
Jun-27-23	Upgrade	Wedbush	Neutral → Outperform	$10
Mar-29-22	Downgrade	Wedbush	Outperform → Neutral
Mar-22-22	Downgrade	H.C. Wainwright	Buy → Neutral
Sep-30-21	Initiated	Stifel	Hold	$10
Jan-07-21	Initiated	Wedbush	Outperform	$45
Nov-24-20	Initiated	Berenberg	Buy	$58
May-04-20	Initiated	H.C. Wainwright	Buy	$53
Feb-24-20	Initiated	JP Morgan	Overweight	$42
Feb-24-20	Initiated	Jefferies	Buy
Feb-24-20	Initiated	Cowen	Outperform
Feb-24-20	Initiated	Canaccord Genuity	Buy	$50

Show Previous Ratings

Apr-25-24 09:55AM	Does Black Diamond (BDTX) Have the Potential to Rally 152.96% as Wall Street Analysts Expect? (Zacks)
Apr-24-24 04:05PM	Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
Apr-23-24 07:45AM	Garry Menzel joins GHO Capital as Operating Partner (GlobeNewswire)
Apr-15-24 12:00PM	Black Diamond (BDTX) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Apr-11-24 08:00AM	Black Diamond Therapeutics Announces Changes to Board of Directors (GlobeNewswire) +11.85%
09:55AM	Loading…
Apr-08-24 09:55AM	Wall Street Analysts Predict a 129.25% Upside in Black Diamond (BDTX): Here's What You Should Know (Zacks) +5.73%
Apr-07-24 06:00PM	Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting (GlobeNewswire)
Apr-03-24 08:00AM	Black Diamond Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire) +5.71%
Mar-22-24 09:55AM	How Much Upside is Left in Black Diamond Therapeutics (BDTX)? Wall Street Analysts Think 95.93% (Zacks) +6.10%
Mar-14-24 05:31AM	Black Diamond Therapeutics Inc (BDTX) Reports Q4 and Full Year 2023 Financials, Advances ... (GuruFocus.com) +8.35%
Mar-12-24 08:32AM	Black Diamond: Q4 Earnings Snapshot (Associated Press Finance) -5.50%
08:00AM	Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-05-24 04:30PM	Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024 (GlobeNewswire)
Feb-28-24 08:00AM	Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference (GlobeNewswire)
Jan-04-24 08:00AM	Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones (GlobeNewswire)
07:00AM	Loading…
Dec-13-23 07:00AM	Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM (GlobeNewswire) -9.03%
Nov-07-23 08:00AM	Black Diamond Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-06-23 08:07AM	Black Diamond Therapeutics Inc (BDTX) Reports Q3 2023 Financial Results and Corporate Update (GuruFocus.com)
07:48AM	Black Diamond: Q3 Earnings Snapshot (Associated Press Finance)
07:45AM	Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Oct-20-23 12:54PM	Hedge Fund and Insider Trading News: John Paulson, Sanjay Shah, Doug Kass, Point72 Asset Management, Balyasny Asset Management, Black Diamond Therapeutics, Inc. (BDTX), Delta Air Lines, Inc. (DAL), and More (Insider Monkey)
Oct-14-23 12:30PM	Black Diamond Therapeutics Presents Dose Escalation Data Demonstrating Durable Responses in Patients with NSCLC from Phase 1 Trial of BDTX-1535 (GlobeNewswire)
Oct-04-23 12:14PM	Black Diamond Therapeutics to Present Preclinical and Clinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (GlobeNewswire) -5.56%
Sep-18-23 12:34PM	Co-founder of cancer biotech Black Diamond replaced as CEO (American City Business Journals)
07:00AM	Black Diamond Therapeutics Announces CEO Transition (GlobeNewswire)
Sep-11-23 08:00AM	Black Diamond Therapeutics Announces First Patients Dosed in Phase 1 Clinical Trial Expansion Cohorts Evaluating BDTX-1535 in Patients with Intrinsic Driver and Acquired Resistance EGFR Mutation Positive Non-Small Cell Lung Cancer (GlobeNewswire)
Sep-05-23 08:00AM	Black Diamond Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-17-23 09:56AM	10 Healthcare Stocks with Insider Buying (Insider Monkey)
Aug-11-23 07:35AM	Black Diamond: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
07:43AM	Loading…
Jul-25-23 07:43AM	Is Black Diamond Therapeutics (NASDAQ:BDTX) In A Good Position To Invest In Growth? (Simply Wall St.)
Jul-16-23 10:05AM	TipRanks Perfect 10 List: These Monster Growth Stocks Could Reach New Highs (TipRanks)
Jun-29-23 08:57PM	Black Diamond Therapeutics Announces Pricing of Public Offering of Common Stock (GlobeNewswire) -12.22%
05:48PM	Why Shares of Black Diamond Therapeutics Skyrocketed This Week (Motley Fool)
Jun-28-23 04:23PM	Black Diamond Therapeutics Announces Proposed Public Offering of Common Stock (GlobeNewswire) -7.28%
07:15AM	Institutions profited after Black Diamond Therapeutics, Inc.'s (NASDAQ:BDTX) market cap rose US$152m last week but private equity firms profited the most (Simply Wall St.)
Jun-27-23 07:00AM	Black Diamond Therapeutics Announces Initial Dose Escalation Data Demonstrating Anti-Tumor Activity of BDTX-1535 in Non-Small Cell Lung Cancer Patients Across Multiple EGFR Mutation Families (GlobeNewswire) +235.87%
Jun-13-23 08:00AM	Black Diamond Therapeutics Announces Promotion of Melanie Morrison to Chief Development Officer (GlobeNewswire) +5.34%
Jun-02-23 08:00AM	Black Diamond Therapeutics to Present at the Jefferies Healthcare Conference (GlobeNewswire) +8.84%
May-18-23 10:17AM	Black Diamond Therapeutics Insider Ups Holding By 82% During Year \ (Simply Wall St.) -6.36%
May-09-23 07:46AM	Black Diamond: Q1 Earnings Snapshot (AP Finance) -5.21%
07:30AM	Black Diamond Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Apr-18-23 08:00AM	Black Diamond Therapeutics to Present at the Stifel 2023 Targeted Oncology Days (GlobeNewswire)
Apr-17-23 04:01PM	Black Diamond Therapeutics Presents Trial in Progress Poster for BDTX-1535 and Preclinical Data on BDTX-1535 and BDTX-4933 at the 2023 American Association of Cancer Research Annual Meeting (GlobeNewswire)
Mar-09-23 07:52AM	Black Diamond: Q4 Earnings Snapshot (AP Finance) -13.69%
07:30AM	Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Feb-27-23 08:00AM	Black Diamond Therapeutics to Present at the Cowen 43rd Annual Health Care Conference (GlobeNewswire) -9.31%
Feb-15-23 05:46AM	Is Black Diamond Therapeutics (NASDAQ:BDTX) In A Good Position To Invest In Growth? (Simply Wall St.) -7.72%
Jan-19-23 05:41AM	private equity firms who own 40% along with institutions invested in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) saw increase in their holdings value last week (Simply Wall St.)
Jan-05-23 08:00AM	Black Diamond Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-19-22 08:00AM	Black Diamond Therapeutics Announces Changes to Board of Directors (GlobeNewswire)
Dec-12-22 08:00AM	Black Diamond Therapeutics Announces Spinout of Launchpad Therapeutics, Inc., an Antibody-Focused Precision Oncology Company (GlobeNewswire)
Dec-09-22 09:35AM	Down 32.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Black Diamond (BDTX) (Zacks)
09:04AM	Black Diamond Therapeutics, Inc.'s (NASDAQ:BDTX) recent US$17m market cap decline means a loss of US$21k for insiders who bought this year (Simply Wall St.)
Nov-09-22 08:00AM	Black Diamond Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire) -5.70%
Nov-08-22 08:00AM	Black Diamond Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Oct-26-22 08:00AM	Black Diamond Therapeutics Presents Preclinical Data on BDTX-1535 and BDTX-4933 at the 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (GlobeNewswire)
Sep-06-22 08:00AM	Black Diamond Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire) -6.51%
Aug-28-22 09:41AM	We Think Black Diamond Therapeutics (NASDAQ:BDTX) Needs To Drive Business Growth Carefully (Simply Wall St.)
Aug-09-22 08:00AM	Black Diamond Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-03-22 08:00AM	Black Diamond Therapeutics to Present at the 2022 Wedbush PacGrow Healthcare Virtual Conference (GlobeNewswire)
Aug-01-22 08:55AM	Could The Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Ownership Structure Tell Us Something Useful? (Simply Wall St.)
Jul-02-22 08:29AM	CFO, Principal Financial Officer and Chief Business Officer Fang Ni Just Bought 57% More Shares In Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) (Simply Wall St.)
Jun-06-22 08:00AM	Black Diamond Therapeutics to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
Jun-01-22 07:00AM	Black Diamond Therapeutics Appoints Sergey Yurasov, M.D., Ph.D., as Chief Medical Officer (GlobeNewswire)
May-17-22 07:00AM	Black Diamond Therapeutics to Present at the H.C. Wainwright Global Investment Conference (GlobeNewswire) +5.91%
May-12-22 04:30PM	Black Diamond Therapeutics Announces Publication of New Computational and Functional Analyses of HER2 Mutations Based on its Proprietary MAP Discovery Engine (GlobeNewswire)
May-11-22 04:30PM	Black Diamond Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire) -7.88%
Apr-28-22 12:52PM	Two years after massive IPO, cancer startup makes workforce cuts (American City Business Journals)
Apr-25-22 09:00AM	Black Diamond Therapeutics Announces Pipeline Prioritization and Workforce Realignment (GlobeNewswire)
Apr-18-22 07:00AM	Black Diamond Therapeutics Announces First Patient Dosed in Phase 1 Study of BDTX-1535, a MasterKey Inhibitor of EGFR for the Treatment of Glioblastoma and Non-Small Cell Lung Cancer (GlobeNewswire)
Apr-07-22 04:30PM	Black Diamond Therapeutics to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference (GlobeNewswire) +14.14%
07:00AM	Black Diamond Therapeutics Appoints Wendy L. Dixon to its Board of Directors (GlobeNewswire)
Mar-17-22 05:00PM	Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-02-22 08:00AM	Black Diamond Therapeutics to Participate at the Cowen 42nd Annual Health Care Conference (GlobeNewswire)
Feb-22-22 08:00AM	Black Diamond Therapeutics Appoints Elizabeth Montgomery as Chief People Officer (GlobeNewswire) -5.65%
Feb-16-22 05:28AM	Will Black Diamond Therapeutics (NASDAQ:BDTX) Spend Its Cash Wisely? (Simply Wall St.)
Jan-11-22 07:00AM	Black Diamond Therapeutics Announces FDA Allowance of IND Application for BDTX-1535, A MasterKey Inhibitor of EGFR for the Treatment of Gliobastoma and Non-Small Cell Lung Cancer (GlobeNewswire) +13.33%
Jan-10-22 07:00AM	Black Diamond Therapeutics Announces Strategic Priorities and Expected Milestones for 2022 (GlobeNewswire) -11.76%
Jan-05-22 08:00AM	Black Diamond Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-18-21 05:27AM	What You Need To Know About Black Diamond Therapeutics, Inc.'s (NASDAQ:BDTX) Investor Composition (Simply Wall St.)
Nov-08-21 04:05PM	Black Diamond Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire)
07:45AM	Black Diamond Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update (GlobeNewswire)
Oct-08-21 04:05PM	Black Diamond Therapeutics Presents Preclinical Data on BDTX-1535, BRAF, and FGFR Programs at the 33rd AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (GlobeNewswire)
Oct-04-21 11:02AM	Is Black Diamond Therapeutics, Inc. (BDTX) Going to Burn These Hedge Funds? (Insider Monkey)
Sep-30-21 04:35PM	Black Diamond Therapeutics to Present Pre-Clinical Data on BDTX-1535, BRAF, and FGFR Programs at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (GlobeNewswire) -6.62%
Sep-21-21 04:05PM	Black Diamond Therapeutics to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference (GlobeNewswire)
07:45AM	Black Diamond Therapeutics and OpenEye Scientific Announce Collaboration to Expand MAP Drug Discovery Platform (GlobeNewswire)
Aug-12-21 08:22AM	Black Diamond Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-10-21 07:45AM	Black Diamond Therapeutics Announces Appointment of Mark Velleca, M.D., Ph.D. to Board of Directors (GlobeNewswire)
Aug-04-21 07:45AM	Black Diamond Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-02-21 02:26AM	We're Not Very Worried About Black Diamond Therapeutics' (NASDAQ:BDTX) Cash Burn Rate (Simply Wall St.)
Jul-29-21 03:53PM	Is Black Diamond Therapeutics, Inc. (BDTX) A Good Stock To Buy? (Insider Monkey)
May-19-21 05:00PM	Black Diamond Therapeutics Presents Phase 1 Pharmacokinetic, Safety, and Preliminary Efficacy Data of BDTX-189 in Advanced Solid Tumors Harboring EGFR or HER2 Alterations (GlobeNewswire)
May-17-21 07:45AM	Black Diamond Therapeutics to Host Webcast Presentation of Data From Phase 1 Dose-Escalation Portion of MasterKey-01 Clinical Trial (GlobeNewswire) -8.87%
May-07-21 07:45AM	Black Diamond Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update (GlobeNewswire)
May-04-21 02:01AM	Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Insiders Increased Their Holdings (Simply Wall St.)
Apr-28-21 10:38AM	Black Diamond Therapeutics to Present Phase 1 BDTX-189 Data in Advanced Solid Tumors at American Society of Clinical Oncology (GlobeNewswire)
Apr-10-21 08:30AM	Black Diamond Therapeutics Announces Preclinical Data Presentations on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting (GlobeNewswire)
Mar-25-21 07:45AM	Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update (GlobeNewswire)

Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BIOTECH GROWTH N V	10% Owner	Oct 17 '23	Buy	2.34	400,000	934,080	8,517,839	Oct 19 03:08 PM
Behbahani Ali	Director	Jul 05 '23	Buy	5.00	1,000,000	5,000,000	4,448,757	Jul 06 04:45 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Jul 05 '23	Buy	5.00	935,850	4,679,250	3,213,828	Jul 07 04:30 PM
BIOTECH GROWTH N V	10% Owner	Jun 30 '23	Buy	5.00	1,000,000	5,000,000	8,117,839	Jul 03 03:36 PM
BIOTECH GROWTH N V	10% Owner	Jun 27 '23	Buy	5.49	1,740,000	9,555,036	7,117,839	Jun 29 01:37 PM
Epstein David M.	SEE REMARKS	Jun 27 '23	Sale	6.70	25,000	167,500	671,423	Jun 28 04:02 PM

Open in Screener

CRSP

CRISPR Therapeutics AG

Apr 26 • 04:00PM ET

53.91

Dollar change +0.18
Percentage change 0.34	%

Healthcare • Biotechnology • Switzerland • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: ARKK ARKG VXF IBB SCHA VHT XT SCHM LABU ITOT

Index	-	P/E	-	EPS (ttm)	-1.97	Insider Own	5.21%	Shs Outstand	84.88M	Perf Week	-2.07%
Market Cap	4.58B	Forward P/E	-	EPS next Y	-4.06	Insider Trans	-3.49%	Shs Float	80.46M	Perf Month	-23.16%
Income	-153.61M	PEG	-	EPS next Q	-1.35	Inst Own	65.72%	Short Float	18.33%	Perf Quarter	-11.64%
Sales	371.21M	P/S	12.33	EPS this Y	-203.03%	Inst Trans	-0.04%	Short Ratio	8.51	Perf Half Y	29.87%
Book/sh	23.52	P/B	2.29	EPS next Y	30.93%	ROA	-6.87%	Short Interest	14.74M	Perf Year	9.06%
Cash/sh	19.95	P/C	2.70	EPS next 5Y	-	ROE	-8.17%	52W Range	37.55 - 91.10	Perf YTD	-13.88%
Dividend Est.	-	P/FCF	-	EPS past 5Y	10.83%	ROI	-7.29%	52W High	-40.82%	Beta	1.79
Dividend TTM	-	Quick Ratio	17.54	Sales past 5Y	33402.13%	Gross Margin	65.88%	52W Low	43.57%	ATR (14)	2.77
Dividend Ex-Date	-	Current Ratio	17.54	EPS Y/Y TTM	76.72%	Oper. Margin	-53.64%	RSI (14)	26.72	Volatility	4.22% 3.89%
Employees	407	Debt/Eq	0.13	Sales Y/Y TTM	30885.48%	Profit Margin	-41.38%	Recom	2.21	Target Price	87.61
Option/Short	Yes / Yes	LT Debt/Eq	0.12	EPS Q/Q	177.83%	Payout	-	Rel Volume	0.78	Prev Close	53.73
Sales Surprise	42.76%	EPS Surprise	1559.13%	Sales Q/Q	3353333.33%	Earnings	Feb 21 BMO	Avg Volume	1.73M	Price	53.91
SMA20	-11.14%	SMA50	-24.49%	SMA200	-9.50%	Trades		Volume	1,352,559	Change	0.34%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-15-24	Initiated	Wolfe Research	Peer Perform
Dec-11-23	Downgrade	TD Cowen	Market Perform → Underperform	$30
Oct-17-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Sep-27-23	Initiated	Mizuho	Buy	$82
Aug-17-23	Upgrade	Citigroup	Neutral → Buy
May-30-23	Initiated	William Blair	Outperform	$75
Apr-13-23	Initiated	Cantor Fitzgerald	Overweight	$72
Mar-21-23	Initiated	Bernstein	Mkt Perform	$44
Mar-17-23	Initiated	Bryan Garnier	Buy	$70
Mar-07-23	Initiated	Robert W. Baird	Neutral	$46
Oct-11-22	Initiated	Morgan Stanley	Underweight	$37
Aug-09-22	Downgrade	Barclays	Overweight → Equal Weight	$99 → $88
Jun-23-22	Downgrade	Evercore ISI	Outperform → In-line	$66 → $60
Jun-17-22	Initiated	BMO Capital Markets	Outperform	$98
Apr-28-22	Initiated	Credit Suisse	Neutral	$78
Dec-07-21	Initiated	Cowen	Market Perform
Oct-19-21	Initiated	SVB Leerink	Outperform	$126
Jun-14-21	Upgrade	Citigroup	Sell → Neutral	$55 → $132
Apr-21-21	Upgrade	Jefferies	Hold → Buy	$172
Mar-04-21	Initiated	JMP Securities	Mkt Outperform	$160

Show Previous Ratings

Apr-26-24 05:50PM	CRISPR Therapeutics AG (CRSP) Ascends But Remains Behind Market: Some Facts to Note (Zacks)
Apr-25-24 07:00AM	Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth (Reuters)
Apr-22-24 06:00PM	CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why (Zacks)
04:30PM	CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting (GlobeNewswire)
12:49PM	Cathie Wood's Latest Stock Portfolio: Top 10 Stock Picks (Insider Monkey)
10:31PM	Loading…
Apr-19-24 10:31PM	CRISPR Therapeutics Stock (NASDAQ:CRSP) Pushes Lower, But Fundamentals Are Intact (TipRanks)
06:56AM	ChatGPT Stock Predictions: 10 Stocks That Have 10X Potential (Insider Monkey)
Apr-17-24 09:00AM	Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now? (Zacks)
Apr-16-24 06:00PM	CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know (Zacks)
Apr-13-24 08:47AM	3 Magnificent Stocks That Could Double or More by 2030 (Motley Fool)
Apr-11-24 01:10PM	Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024 (InvestorPlace)
Apr-10-24 01:46PM	Innovation in Healthcare: HTECs Q1 2024 Index Rebalance (ETF Trends) -5.29%
Apr-09-24 06:00PM	CRISPR Therapeutics AG (CRSP) Exceeds Market Returns: Some Facts to Consider (Zacks)
10:00AM	Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics (Motley Fool)
Apr-05-24 05:03AM	Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics (Motley Fool)
06:15PM	Loading…
Apr-04-24 06:15PM	CRISPR Therapeutics AG (CRSP) Gains As Market Dips: What You Should Know (Zacks)
Apr-03-24 08:00AM	CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-01-24 08:00AM	CRISPR Therapeutics to Present at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting (GlobeNewswire)
Mar-30-24 06:50AM	3 Unstoppable Stocks to Buy Hand Over Fist in April (Motley Fool)
Mar-28-24 08:39AM	3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition (InvestorPlace)
Mar-27-24 04:50AM	3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000 (Motley Fool)
Mar-25-24 06:15PM	CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know (Zacks)
Mar-24-24 10:08AM	Cathie Wood's Stock Portfolio: 2024 Stock Picks (Insider Monkey)
Mar-23-24 06:45AM	Buying These Dirt-Cheap Stocks Could Be a Brilliant Move (Motley Fool)
Mar-22-24 11:30AM	CRISPR Therapeutics (CRSP) Down 13.6% Since Last Earnings Report: Can It Rebound? (Zacks)
Mar-21-24 04:19PM	3 Stocks That Could Be the Next Big Thing in Gene Editing (InvestorPlace)
Mar-20-24 01:49PM	3 Biopharma Stocks Predicted to Soar in Q2 2024 (InvestorPlace)
Mar-19-24 06:15PM	CRISPR Therapeutics AG (CRSP) Outperforms Broader Market: What You Need to Know (Zacks)
12:07AM	Insider Sell: CFO Raju Prasad Sells Shares of CRISPR Therapeutics AG (CRSP) (GuruFocus.com)
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
08:45AM	Loading…
Mar-16-24 08:45AM	Is It Too Late to Buy CRISPR Therapeutics Stock? (Motley Fool)
Mar-14-24 08:15AM	MaxCyte, Inc. (NASDAQ:MXCT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-13-24 02:25PM	7 Biotech Stocks to Buy as Sector Rotation Ramps Up (InvestorPlace)
08:30AM	CRISPR Therapeutics Proposes New Appointment to the Board of Directors (GlobeNewswire)
Mar-06-24 02:45PM	The Top 3 Biotech Stocks to Buy in March 2024 (InvestorPlace)
Mar-05-24 06:53PM	Here's Why CRISPR Therapeutics Stock Climbed 34% in February (Motley Fool)
Mar-04-24 11:02AM	ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential (InvestorPlace)
08:48AM	12 Tech Stocks To Sell Right Now According To Cathie Wood (Insider Monkey)
Feb-29-24 05:32PM	Crispr Therapeutics CEO: Science in gene editing is moving at break-neck speed (CNBC TV)
06:31AM	CRISPR Therapeutics Stock Has 32% Upside, According to 1 Wall Street Analyst (Motley Fool)
05:50AM	A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now (Motley Fool)
Feb-27-24 12:00PM	3 Biotech Stocks Bound to Blast Off By 2029 (InvestorPlace)
Feb-26-24 08:50AM	3 Biotech Stocks to Buy and Hold for the Next 10 Years (Motley Fool)
06:45AM	Missed Out on CRISPR Therapeutics? My Best Gene-Editing Stock to Buy and Hold (Motley Fool)
Feb-23-24 10:01AM	Analyst Report: CRISPR Therapeutics AG (Morningstar Research)
Feb-22-24 07:37AM	CRISPR (CRSP) Q4 Earnings Top on Collaboration Revenues, Stock Up (Zacks)
04:00AM	13 Best Short Squeeze Stocks To Buy Now (Insider Monkey)
Feb-21-24 04:32PM	Crispr Stock Whipsaws As Wall Street Watches Its Gene-Editing Blockbuster Candidate (Investor's Business Daily)
10:15AM	Crispr Reports Its First Profit In 10 Quarters, But Shares Trade Sideways (Investor's Business Daily)
07:30AM	CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-20-24 05:02AM	Cathie Wood Is Betting on This Top Technology: 2 Stocks She Just Bought (Motley Fool)
Feb-19-24 04:08PM	3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential (InvestorPlace)
01:45AM	If You Invested $10,000 in CRISPR Therapeutics in 2019, This Is How Much You Would Have Today (Motley Fool)
Feb-16-24 02:19PM	3 Stocks That Cathie Wood Is Loving Now: February 2024 (InvestorPlace)
07:31AM	CRISPR Therapeutics AG (CRSP) Moves 6.9% Higher: Will This Strength Last? (Zacks)
Feb-15-24 08:30AM	CRISPR Therapeutics to Present at the Citi 2024 Virtual Oncology Leadership Summit (GlobeNewswire) +6.88%
Feb-14-24 08:15AM	CRISPR (CRSP) to Report Q4 Earnings: What's in the Cards? (Zacks) +8.60%
Feb-13-24 01:22PM	CRISPR Therapeutics Stock Shows Rising Relative Strength, Hits 90+ (Investor's Business Daily)
10:00AM	CRISPR Therapeutics AG (CRSP) May Report Negative Earnings: Know the Trend Ahead of Q4 Release (Zacks)
08:30AM	CRISPR Therapeutics Announces $280 Million Registered Direct Offering (GlobeNewswire)
02:30AM	European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT) (GlobeNewswire)
Feb-10-24 05:09PM	Top 11 CRISPR Stocks To Invest In (Insider Monkey)
Feb-09-24 06:00PM	CRISPR Therapeutics AG (CRSP) Laps the Stock Market: Here's Why (Zacks)
Feb-08-24 02:59AM	2 Healthcare Stocks to Buy Hand Over Fist in February (Motley Fool)
Feb-07-24 10:00AM	Cathie Wood Just Bought These 3 Biotech Stocks. Should You? (Motley Fool)
09:09AM	Jim Cramer Says You Should Stay Away from These 10 Stocks (Insider Monkey)
Feb-05-24 08:00AM	2 Cathie Wood Stocks I Plan on Buying for My Kids' Portfolios (Motley Fool)
Feb-04-24 02:35PM	Got $100? 2 Top Cathie Wood Stocks to Buy and Hold. (Motley Fool)
Feb-02-24 06:00PM	CRISPR Therapeutics AG (CRSP) Rises But Trails Market: What Investors Should Know (Zacks)
Feb-01-24 09:10PM	Top Stock Picks 2024: 3 Healthcare Stocks Leading Medical Advancements (InvestorPlace)
Jan-31-24 12:28PM	3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential (InvestorPlace)
Jan-30-24 05:10AM	History Says the S&P 500 May Climb in the Triple Digits During This Bull Market. 3 Top Growth Stocks to Buy Before it Does. (Motley Fool)
05:02AM	Is CRISPR Therapeutics a Buy in the New Bull Market? (Motley Fool)
Jan-28-24 05:10AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought Last Week (Motley Fool)
Jan-25-24 06:15PM	CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know (Zacks)
08:32AM	Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January (InvestorPlace)
Jan-24-24 09:45AM	Where Will CRISPR Therapeutics Be in 5 Years? (Motley Fool)
Jan-23-24 09:30AM	1 Setback and 1 Opportunity for CRISPR Therapeutics Stock (Motley Fool)
Jan-22-24 09:12AM	Cathie Woods Latest Stock Picks: 11 Biggest Positions (Insider Monkey) +5.28%
05:05AM	Could CRISPR Therapeutics Stock Help You Become a Millionaire? (Motley Fool)
Jan-21-24 09:37AM	Could Editas Medicine Become the Next CRISPR Therapeutics? (Motley Fool)
08:00AM	Better Growth Stock: Intellia Therapeutics vs. CRISPR Therapeutics (Motley Fool)
Jan-20-24 06:50AM	3 High-Flying Stocks That Could Soar Even More in 2024 (Motley Fool)
Jan-19-24 06:15PM	CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jan-16-24 04:08PM	Crispr Wins Its Second Gene-Editing Approval In Another Boost To Vertex Stock (Investor's Business Daily)
04:01PM	CRISPR Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval of CASGEVY (exagamglogene autotemcel) for the Treatment of Transfusion-Dependent Beta Thalassemia (GlobeNewswire)
08:15AM	These 2 Stocks Carry a Lot of Risk, but Their Upside Is Huge (Motley Fool)
Jan-15-24 04:56PM	Here's Why CRISPR Therapeutics Stock Rose 54% Last Year (Motley Fool)
06:30AM	5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond (Motley Fool)
05:19AM	Down 88%, Could Editas Medicine Be a Good Investment Now? (Motley Fool)
Jan-14-24 01:30PM	What Does It Mean for Investors if CRISPR Therapeutics Gets Bought Out in 2024? (Motley Fool)
05:10AM	My 5 Top Growth Stocks to Buy Hand Over Fist for 2024 (Motley Fool)
Jan-13-24 06:05AM	The Top Healthcare Stocks to Buy With $100 (Motley Fool)
05:20AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought This Week (Motley Fool)
Jan-10-24 06:00AM	3 Cathie Wood Stocks to Start Off Your New Year Right (Motley Fool)
Jan-09-24 06:15PM	CRISPR Therapeutics AG (CRSP) Stock Moves -0.1%: What You Should Know (Zacks)
Jan-08-24 09:17AM	Vertex cuts ties to CRISPR Therapeutics' type 1 diabetes stem cell therapy (FierceBiotech.com)
07:00AM	CRISPR Therapeutics Highlights Strategic Priorities and 2024 Outlook (GlobeNewswire)
05:00AM	The Ultimate Growth Stock to Buy With $1,000 Right Now (Motley Fool)
Jan-06-24 05:00AM	5 Innovative Stocks That Could Score a Win for Your Portfolio in 2024 (Motley Fool)

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kulkarni Samarth	Chief Executive Officer	Apr 15 '24	Option Exercise	19.12	19,582	374,408	227,704	Apr 17 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Apr 15 '24	Sale	59.91	19,582	1,173,232	208,122	Apr 17 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Mar 15 '24	Option Exercise	19.12	20,000	382,400	228,122	Mar 18 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Mar 15 '24	Sale	72.48	20,000	1,449,628	208,122	Mar 18 05:45 PM
Prasad Raju	Chief Financial Officer	Mar 15 '24	Sale	72.69	3,524	256,160	6,476	Mar 18 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Mar 12 '24	Sale	74.44	4,583	341,159	208,122	Mar 12 05:45 PM
KASINGER JAMES R.	General Counsel and Secretary	Mar 12 '24	Sale	74.44	1,146	85,308	61,174	Mar 12 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Mar 11 '24	Sale	78.26	9,802	767,105	203,705	Mar 12 05:45 PM
KASINGER JAMES R.	General Counsel and Secretary	Mar 11 '24	Sale	78.26	2,801	219,206	60,070	Mar 12 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Feb 20 '24	Sale	79.67	6,370	507,498	194,257	Feb 21 05:45 PM
KASINGER JAMES R.	General Counsel and Secretary	Feb 20 '24	Sale	79.67	1,913	152,409	57,371	Feb 21 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Feb 15 '24	Option Exercise	19.12	20,000	382,400	207,377	Feb 16 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Feb 15 '24	Sale	80.36	20,000	1,607,177	187,377	Feb 16 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Jan 29 '24	Option Exercise	19.12	50,000	956,000	237,377	Jan 31 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Jan 29 '24	Sale	60.51	50,000	3,025,573	187,377	Jan 31 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Jan 16 '24	Option Exercise	19.12	20,000	382,400	207,377	Jan 18 05:45 PM
Kulkarni Samarth	Chief Executive Officer	Jan 16 '24	Sale	62.50	20,000	1,250,058	187,377	Jan 18 05:45 PM
Kulkarni Samarth	Chief Executive Officer	May 30 '23	Option Exercise	19.12	25,000	478,000	412,377	Jun 01 05:44 PM
Kulkarni Samarth	Chief Executive Officer	May 30 '23	Sale	64.88	25,000	1,621,894	387,377	Jun 01 05:44 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

BDTX

Black Diamond Therapeutics Inc

CRSP

CRISPR Therapeutics AG

Upgrade your FINVIZ experience